Taking low-dose aspirin while undergoing cancer treatment may increase survival

“This is a clever research protocol. My hat is off to the originator for considering the bacteria we live with may be related to some of our maladies.” Bill Chesnut, MD

To go back to New Health News: http://billchesnutmd.com/new-health-news

Taking low-dose aspirin while undergoing cancer treatment may increase likelihood of survival, study suggests

Newsweek (4/20, Firger) reports that research suggests “taking low-dose aspirin while undergoing cancer treatment may increase a patient’s chance of survival by as much as 20 percent.” The findings (4/21) were published in PLOS ONE. Researchers looked at data from “five randomized trials and 42 observational studies on patients with breast, prostate and colorectal cancers.” The investigators “found there was a significant reduction in mortality in patients who took daily low-dose aspirin.”

Medical Daily (4/20, Baulkman) reports that aspirin also “helped stop the cancer from spreading.” These “findings echo findings from previous studies.”

 

AMA wire newsletter, April 21, 2016.